Figure 3.
Proportion of patients experiencing anxiety (in orange) at time of filling in the survey regarding disease recurrence/progression (A); long-term AEs (B); getting an infection (C); and getting COVID-19 in particular (D); and impact of this anxiety on their everyday life (in blue).